Painkiller Drug Development Is Booming, New Report Shows - But Pharmas Should Do Comparative Testing, Suggests Queen's Anesthesiologist

... The number of new drugs being developed to relieve neuropathic pain - a chronic, devastating condition affecting three to eight per cent of the population - has quadrupled over the past year and a half, a Queen's University study shows. But under present regulations, pharmaceutical companies are not required to test their products against currently used neuropathic pain drugs, notes Dr. [click link for full article] ...